Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€9.89

€9.89

2.160%
0.209
2.160%
€12.95
 
16:36 / Tradegate WKN: A2JQ1X / Symbol: BHC / Name: Bausch Health Companies / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Bausch Health Companies Inc. Stock

There is an upward development for Bausch Health Companies Inc. compared to yesterday, with an increase of €0.21 (2.160%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Bausch Health Companies Inc. stock is not clear.
As a result the target price of 12 € shows a positive potential of 21.3% compared to the current price of 9.89 € for Bausch Health Companies Inc..
For the coming years our community has positive and negative things to say abot the Bausch Health Companies Inc. stock. Criterium "Management" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Bausch Health Companies Inc. in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Bausch Health Companies Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Bausch Health Companies Inc. 2.160% 10.346% 14.455% 40.246% 33.352% -63.151% -55.167%
Opko Health Inc. 10.990% 22.561% 4.494% -17.774% -30.007% -73.656% -54.457%
Catalent Inc. 0.380% 1.758% -2.980% -16.680% 26.456% -40.115% 44.321%
Repligen Corp. -0.590% -6.565% -3.829% 10.422% 1.909% 9.698% -

Comments

Prediction Buy
Perf. (%) 25.23%
Target price 12.949
Change
Ends at 20.02.25

Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $16.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for BHC provided by MarketBeat
Show more

Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BHC provided by MarketBeat
Show more

Sell Bausch Health Companies Inc.
Show more

News

CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad  Receive Registration Certifications in China
CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China

Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets

 

(*CORRECTION to the release that was posted earlier on January 18, 2024: The TR-4 Return Pad i